The Significance of disintegration testing in pharmaceutical development (2018)
Silva, Daniela Amaral; Webster, Gregory K; Bou-Chacra, Nadia Araci 
; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 13 out. 2024.APA
Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30NLM
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 13 ] Available from: https://doi.org/10.14227/DT250318P30Vancouver
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 13 ] Available from: https://doi.org/10.14227/DT250318P30
